New River to co-promote NRP104

By Elaine Rigoli

Tampa, Fla., July 25 - New River Pharmaceuticals Inc. announced its first exercise of its right to co-promote NRP104 in the United States, including territories and possessions.

NRP104 is the subject of a collaboration between New River and Shire plc.

The co-promotion activities of New River will start in six months or upon the commercial launch of NRP104, whichever occurs later, the company said in a news release.

In exercising its option to co-promote NRP104, New River will co-promote the product for at least 24 months and provide 25% of the total details for the product during the 24-month period.

New River is a specialty pharmaceutical company located in Radford, Va.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.